Copper in Alzheimer’s disease: Implications in amyloid aggregation and neurotoxicity

The relationship of copper dyshomeostasis with neurodegenerative diseases has become evident in the last years. Because of the major role that this metal ion plays in biological processes, most of which being located in the brain, it is not surprising that changes in its distribution are closely rel...

Full description

Bibliographic Details
Main Authors: Patrick Gamez, Ana B. Caballero
Format: Article
Language:English
Published: AIP Publishing LLC 2015-09-01
Series:AIP Advances
Online Access:http://dx.doi.org/10.1063/1.4921314
_version_ 1819160294055739392
author Patrick Gamez
Ana B. Caballero
author_facet Patrick Gamez
Ana B. Caballero
author_sort Patrick Gamez
collection DOAJ
description The relationship of copper dyshomeostasis with neurodegenerative diseases has become evident in the last years. Because of the major role that this metal ion plays in biological processes, most of which being located in the brain, it is not surprising that changes in its distribution are closely related with the advent of neurodegenerative disorders such as Alzheimer’s disease (AD). An increasing number of works have dealt with this subject in the last years, and opened an intense debate in some points while raising new questions that still remain unanswered. This revision work puts together and discusses the latest findings and insights on how copper ions are involved in AD progression, including its interaction with Aβ and its consequently induced aggregation.
first_indexed 2024-12-22T16:54:09Z
format Article
id doaj.art-4909d51f09ec4c168051b0ab835e4035
institution Directory Open Access Journal
issn 2158-3226
language English
last_indexed 2024-12-22T16:54:09Z
publishDate 2015-09-01
publisher AIP Publishing LLC
record_format Article
series AIP Advances
spelling doaj.art-4909d51f09ec4c168051b0ab835e40352022-12-21T18:19:30ZengAIP Publishing LLCAIP Advances2158-32262015-09-0159092503092503-1210.1063/1.4921314005595ADVCopper in Alzheimer’s disease: Implications in amyloid aggregation and neurotoxicityPatrick Gamez0Ana B. Caballero1Departament de Química Inorgànica, QBI, Universitat de Barcelona, Martí i Franquès 1-11, 08028 Barcelona, SpainDepartament de Química Inorgànica, QBI, Universitat de Barcelona, Martí i Franquès 1-11, 08028 Barcelona, SpainThe relationship of copper dyshomeostasis with neurodegenerative diseases has become evident in the last years. Because of the major role that this metal ion plays in biological processes, most of which being located in the brain, it is not surprising that changes in its distribution are closely related with the advent of neurodegenerative disorders such as Alzheimer’s disease (AD). An increasing number of works have dealt with this subject in the last years, and opened an intense debate in some points while raising new questions that still remain unanswered. This revision work puts together and discusses the latest findings and insights on how copper ions are involved in AD progression, including its interaction with Aβ and its consequently induced aggregation.http://dx.doi.org/10.1063/1.4921314
spellingShingle Patrick Gamez
Ana B. Caballero
Copper in Alzheimer’s disease: Implications in amyloid aggregation and neurotoxicity
AIP Advances
title Copper in Alzheimer’s disease: Implications in amyloid aggregation and neurotoxicity
title_full Copper in Alzheimer’s disease: Implications in amyloid aggregation and neurotoxicity
title_fullStr Copper in Alzheimer’s disease: Implications in amyloid aggregation and neurotoxicity
title_full_unstemmed Copper in Alzheimer’s disease: Implications in amyloid aggregation and neurotoxicity
title_short Copper in Alzheimer’s disease: Implications in amyloid aggregation and neurotoxicity
title_sort copper in alzheimer s disease implications in amyloid aggregation and neurotoxicity
url http://dx.doi.org/10.1063/1.4921314
work_keys_str_mv AT patrickgamez copperinalzheimersdiseaseimplicationsinamyloidaggregationandneurotoxicity
AT anabcaballero copperinalzheimersdiseaseimplicationsinamyloidaggregationandneurotoxicity